Updated Jul 16, 2026
Chan Andrew C. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Andrew C. Chan is associated with Corvus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing immuno-oncology therapies. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
Andrew C. Chan is associated with Corvus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing immuno-oncology therapies. Specific details about his role and contributions to the company are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chan Andrew C. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.